The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOEX.L Regulatory News (OEX)

  • There is currently no data for OEX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Amendment to Series A Loan Funding Agreement

23 Jul 2019 10:14

RNS Number : 4241G
Oilex Ltd
23 July 2019
 

ASX Announcement

 

23 July 2019

 

ASX: OEX

AIM: OEX

 

Amendment to Series A Loan Funding Agreement

 

Oilex Ltd (the Company) is pleased to advise that it has entered into an amendment agreement to vary the terms of its loan funding facility of A$330,000 (Amendment) entered into on 26 July 2018 (Series A Loan).

 

Pursuant to the Amendment, the loan repayment date has been extended from 26 July 2019 to 1 October 2019. In addition, the Company will issue 124,060,150 new options to the lenders at an exercise price of $0.00266. All other terms remain the same as the Series A Loan and are extended to 1 October 2019.

 

Summary of Key Terms after the Amendment

 

Term: 1 October 2019

Interest Rate: 5%

Repayments 100% payable at maturity

Options Issued: 124,060,150 options over ordinary shares

Option Exercise Price: A$0.00266 per option

Option Expiry Date: On 31 December 2019

Security: Unsecured

Key Undertakings: Not to dispose of assets having an aggregate value more than A$1 million

Not to incur any financial indebtedness more than A$50,000

Not to incur any aggregate payment or outgoing exceeding A$1 million (except for wages)

 

Customary additional provisions regarding events of default, undertakings, covenants and representations and warranties remain unchanged.

 

The options, which if exercised in their entirety, will result in a cash inflow to the Company of A$330,000. The proceeds from the conversion of options will be applied to the outstanding Series A Loan balance, which is fully drawn down.

 

The issue of the options is subject to shareholder approval under ASX Listing Rule 7.1 on or before 30 September 2019. Failure to secure shareholder approval will require immediate repayment of the loan principal and accrued interest. The Company is currently preparing the necessary notice of general meeting, which will be sent to shareholders shortly.

 

Related Party Transaction

 

Republic Investment Management Pte Ltd (Republic) makes up $300,000 of the Series A Loan balance of $330,000. Republic has a shareholding in the Company of 10.53% and is therefore categorised as a Substantial Shareholder of the Company pursuant to the AIM Rules for Companies (AIM Rules). Accordingly, the entering into the Amendment with Republic is classified as a related party transaction pursuant to the AIM Rules.

 

 

The Directors of the Company, having consulted with Strand Hanson Limited, the Company's Nominated Adviser, consider that the terms of the Amendment with Republic are fair and reasonable insofar as the Company's shareholders are concerned.

 

 

For and on behalf of Oilex Ltd

 

Mark Bolton

Chief Financial Officer Company Secretary

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

 

For further information, please contact:

 

Investor Enquiries

Oilex Ltd

Joe Salomon

Managing Director

Email: oilex@oilex.com.au

Tel: +61 8 9485 3200

Australia

AIM Broker

Novum Securities

Broker

Colin Rowbury

Email: crowbury@novumsecurities.com

Tel: +44 20 7399 9427

UK

AIM Nominated Adviser

Strand Hanson Limited

Nominated Adviser

Rory Murphy/Ritchie Balmer

Email: oilex@strandhanson.co.uk

Tel: +44 20 7409 3494

UK

Media Enquires (UK)

Vigo Communications

Public Relations

Patrick d'Ancona/Chris McMahon

Email: patrick.dancona@vigocomms.com

chris.mcmahon@vigocomms.com

Tel:+ 44 20 7390 0230

UK

Media Enquiries (Aus)

Citadel-MAGNUS

Michael Weir

Email: mweir@citadelmagnus.com

Tel: +618 6160 4900

Australia

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGRLIFIADAIVFIA
Date   Source Headline
3rd Jan 20207:00 amRNSIssue of Securities
31st Dec 20198:31 amRNSExercise of Options and Underwriting
23rd Dec 20197:30 amRNSEast Irish Sea Licence Acquisition
23rd Dec 20197:15 amRNSBids for Cambay Now Closed
16th Dec 20197:00 amRNSExtension for Acqn of Cooper-Eromanga Licences
2nd Dec 20197:00 amRNSExtension of Bid closing Date for Cambay
29th Nov 20197:57 amRNSIssue of Options Securities
27th Nov 20191:15 pmRNSUpdated Constitution
27th Nov 20197:00 amRNSResults of the Annual General Meeting
26th Nov 20198:53 amRNSCambay PSC Update
11th Nov 20192:05 pmRNSSecond Price Monitoring Extn
11th Nov 20192:00 pmRNSPrice Monitoring Extension
11th Nov 20197:00 amRNSExtension of Bid Closing Date for Cambay
7th Nov 20197:37 amRNSChange of Interests of Substantial Holder
5th Nov 20197:00 amRNSIssue of Securities
31st Oct 201912:54 pmRNSSeptember 2019 Quarterly Report
30th Oct 20197:57 amRNSExpanded Equity Capital Raising
28th Oct 20197:00 amRNS2019 AGM Notice of Meeting
28th Oct 20197:00 amRNS2019 Annual Report to Shareholders
22nd Oct 20199:01 amRNSChange of Interests of Substantial Shareholder
21st Oct 201910:15 amRNSIssue of Securities
18th Oct 201912:32 pmRNSCambay PSC Update
15th Oct 20197:00 amRNSIssue of Securities
10th Oct 20194:12 pmRNSNotice of Change of Interest of Substantial Holder
1st Oct 20198:26 amRNSAnnual Report 2019- Financial Report
1st Oct 20198:26 amRNSAnnual Report - Directors Report
1st Oct 20198:21 amRNSAnnual Report - Business Review
1st Oct 20198:20 amRNSAnnual Report - Chairmans Review
1st Oct 20197:00 amRNSAppendix 4G
1st Oct 20197:00 amRNSExtension of Exclusivity Agreement
1st Oct 20197:00 amRNSAmendment to Loan Funding Agreement
1st Oct 20197:00 amRNSCorporate Governance Statement
30th Sep 20198:45 amRNSEquity Raise of GBP0.6m
30th Sep 20197:00 amRNSExecutive Contract Extensions
27th Sep 20192:16 pmRNSCommencement of Cambay Sale Process
27th Sep 20197:00 amRNSAcquisition of Major Cooper-Eromanga Acreage
27th Sep 20197:00 amRNSIssue of Series A Loan Options
24th Sep 20192:01 pmRNSTermination of Arbitration Proceedings
19th Sep 20197:00 amRNSResults of General Meeting
18th Sep 20197:48 amRNSUpdate on Cooper Basin and Cambay
16th Sep 20197:00 amRNSExclusivity Agreement - East Irish Sea Licences
12th Sep 20197:00 amRNSGood Oil Investor Presentation - September 2019
9th Sep 20199:08 amRNSDispute Resolution with GSPC
6th Sep 20197:00 amRNSChairman to Drive Cooper Basin Strategy
5th Sep 20197:00 amRNSAppendix 3X P Schwarz
4th Sep 20198:22 amRNSAppointment of UK Based Non-Executive Director
20th Aug 20197:00 amRNSNotice of General Meeting - 19 September 2019
16th Aug 201911:54 amRNSJPDA Arbitration - Counterclaim for US$23.3m
15th Aug 20197:00 amRNSNotice of Change of Interest of Substantial Holder
14th Aug 20198:44 amRNSIssue of Consideration Securities

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.